Tags

Type your tag names separated by a space and hit enter

Question 12: What do you consider when discussing treatment adherence in patients with Cystic Fibrosis?
Paediatr Respir Rev 2018; 25:33-36PR

Authors+Show Affiliations

Department of Respiratory Medicine, The Children's Hospital at Westmead, Sydney, NSW, Australia; Discipline of Child and Adolescent Health, Sydney Medical School, University of Sydney, Sydney, NSW, Australia.Department of Respiratory Medicine, The Children's Hospital at Westmead, Sydney, NSW, Australia; Discipline of Child and Adolescent Health, Sydney Medical School, University of Sydney, Sydney, NSW, Australia.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

28625493

Citation

Ohn, Mon, and Dominic A. Fitzgerald. "Question 12: what Do You Consider when Discussing Treatment Adherence in Patients With Cystic Fibrosis?" Paediatric Respiratory Reviews, vol. 25, 2018, pp. 33-36.
Ohn M, Fitzgerald DA. Question 12: What do you consider when discussing treatment adherence in patients with Cystic Fibrosis? Paediatr Respir Rev. 2018;25:33-36.
Ohn, M., & Fitzgerald, D. A. (2018). Question 12: What do you consider when discussing treatment adherence in patients with Cystic Fibrosis? Paediatric Respiratory Reviews, 25, pp. 33-36. doi:10.1016/j.prrv.2017.04.002.
Ohn M, Fitzgerald DA. Question 12: what Do You Consider when Discussing Treatment Adherence in Patients With Cystic Fibrosis. Paediatr Respir Rev. 2018;25:33-36. PubMed PMID: 28625493.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Question 12: What do you consider when discussing treatment adherence in patients with Cystic Fibrosis? AU - Ohn,Mon, AU - Fitzgerald,Dominic A, Y1 - 2017/04/27/ PY - 2017/04/19/received PY - 2017/04/19/accepted PY - 2017/6/20/pubmed PY - 2018/10/30/medline PY - 2017/6/20/entrez SP - 33 EP - 36 JF - Paediatric respiratory reviews JO - Paediatr Respir Rev VL - 25 SN - 1526-0550 UR - https://www.unboundmedicine.com/medline/citation/28625493/Question_12:_What_do_you_consider_when_discussing_treatment_adherence_in_patients_with_Cystic_Fibrosis L2 - https://linkinghub.elsevier.com/retrieve/pii/S1526-0542(17)30039-8 DB - PRIME DP - Unbound Medicine ER -